Heidelberg Pharma AG (LON: 0QW5)

Heidelberg Pharma AG Balance Sheet

Financials in millions EUR. Fiscal year is December - November.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug 31, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020	Nov 30, 2019
Cash & Equivalents	36.57	43.44	81.33	6.14	4.98	9.88
Cash & Short-Term Investments	36.57	43.44	81.33	6.14	4.98	9.88
Cash Growth	-27.84%	-46.59%	1224.27%	23.27%	-49.59%	-49.16%
Accounts Receivable	0.03	0.98	1.1	1.02	1.19	1.23
Other Receivables	3.13	1.35	0.35	0.43	0.32	0.18
Receivables	3.16	2.32	1.45	1.45	1.51	1.41
Inventory	12.22	10.49	4.59	0.75	0.23	0.24
Prepaid Expenses	-	-	-	-	-	0.06
Other Current Assets	0.44	0.38	0.51	0.68	0.8	-
Total Current Assets	52.39	56.63	87.88	9.01	7.52	11.59
Property, Plant & Equipment	3.55	3.85	3.72	3.67	3.11	2.43
Long-Term Investments	-	-	-	-	-	0.01
Goodwill	6.11	6.11	6.11	6.11	6.11	6.11
Other Intangible Assets	2.75	2.79	2.84	2.9	2.82	2.8
Other Long-Term Assets	0.98	0.97	0.03	0.03	0.04	0.04
Total Assets	65.77	70.35	100.58	21.73	19.61	22.99
Accounts Payable	5.22	7.88	5.75	2.96	2.81	1.01
Accrued Expenses	-	1.04	1.03	0.78	3.46	3.51
Short-Term Debt	-	5.65	15.79	10.47	-	-
Current Portion of Leases	0.11	0.11	0.09	0.09	0.1	-
Current Unearned Revenue	2.38	4.97	5.02	0.49	0.25	1.94
Other Current Liabilities	1.01	0.13	0.25	0.15	-0	0
Total Current Liabilities	8.72	19.78	27.93	14.93	6.63	6.46
Long-Term Leases	0.04	0.07	0.1	0.08	0.1	-
Long-Term Unearned Revenue	-	1.17	5.9	0.02	-	0.24
Other Long-Term Liabilities	21.18	-	-	-	-	-
Total Liabilities	29.95	21.01	33.94	15.03	6.73	6.7
Common Stock	46.6	46.6	46.58	34.18	31.06	28.21
Additional Paid-In Capital	304.78	304.78	304.74	238.05	221.9	210.36
Retained Earnings	-326	-311.74	-291.39	-271.69	-245.55	-227.18
Comprehensive Income & Other	10.44	9.7	6.71	6.16	5.47	4.9
Shareholders' Equity	35.82	49.34	66.64	6.7	12.88	16.29
Total Liabilities & Equity	65.77	70.35	100.58	21.73	19.61	22.99
Total Debt	0.16	5.83	15.98	10.63	0.2	-
Net Cash (Debt)	36.41	37.61	65.35	-4.49	4.78	9.88
Net Cash Growth	-18.94%	-42.45%	-	-	-51.64%	-49.16%
Net Cash Per Share	0.79	0.81	1.76	-0.14	0.16	0.35
Filing Date Shares Outstanding	44.78	46.6	46.58	34.18	31.06	28.21
Total Common Shares Outstanding	44.78	46.6	46.58	34.18	31.06	28.21
Working Capital	43.67	36.86	59.95	-5.92	0.89	5.13
Book Value Per Share	0.80	1.06	1.43	0.20	0.41	0.58
Tangible Book Value	26.96	40.44	57.7	-2.31	3.95	7.38
Tangible Book Value Per Share	0.60	0.87	1.24	-0.07	0.13	0.26
Machinery	-	10.34	9.5	8.91	7.7	6.62

Source: S&P Capital IQ. Standard template. Financial Sources.